Managing Lupus Kidney Disease During Pregnancy Requires Specialized Care

Lupus nephritis during pregnancy presents a complex medical challenge that requires specialized management to protect both maternal and fetal health. This condition affects women with systemic lupus erythematosus, where pregnancy-induced hormonal and immunological changes can significantly impact disease activity and outcomes.

The physiological changes of pregnancy create a perfect storm for lupus nephritis complications. The altered immune state necessary for fetal tolerance can paradoxically trigger lupus flares, while pregnancy-related kidney changes increase vulnerability to adverse outcomes including preeclampsia, fetal loss, and preterm delivery.

The review emphasizes that successful management begins before conception. Women should achieve well-controlled lupus nephritis before attempting pregnancy, with careful medication optimization. Only specific immunosuppressive drugs are considered safe: hydroxychloroquine should be continued throughout pregnancy, while azathioprine and tacrolimus are the only permitted immunosuppressive options.

Diagnostic procedures require special consideration during pregnancy. Kidney biopsies carry increased risks and should only be performed when results would directly influence treatment decisions. The procedure is relatively safer in early pregnancy but should be avoided when possible.

The authors stress that preconception counseling and planning are crucial for preventing maternal-fetal complications. This proactive approach, combined with specialized nephrology and obstetric care, can significantly improve outcomes for both mother and child in this high-risk population.